More and more research indicates that GLP-1 analogues can have a blunting effect on addictions like drugs and alcohol. Drug ...

DelveInsight's Parkinson's Disease Pipeline report depicts a robust space with 130+ active players working to develop 150+ ...

The average American spends 4 hours and 34 minutes daily on their phone. When we’re not glued to our phones, we’re fixated on ...

DelveInsight's Traumatic Brain Injury pipeline report depicts a robust space with 20+ active players working to develop 22+ ...

Phone addiction rewires brain chemistry by lowering baseline dopamine levels, making normal activities feel boring and ...

Alto Neuroscience Announces Acquisition of Novel Dopamine Agonist Combination Product Candidate, Adding Late-Stage Readout in Treatment Resistant Depression Within Current Cash Runway Published ...

The most advanced program, ALTO-207 (formerly known as CTC-501), is a fixed-dose combination of pramipexole, a dopamine D3-preferring D3/D2 agonist, approved for the treatment of Parkinson’s ...

Discovery of dopamine receptors in a previously overlooked part of the brain sheds light on the complex circuitry for anxiety and depression Date: May 7, 2025 Source: The Mount Sinai Hospital ...